Issue : PJ May 2017 online
Sort by: Newest first Oldest first A-Z Z-A
-
FDA approves first treatment for giant cell arteritis
Subcutaneous tocilizumab (marketed as Actemra) has been approved by the US drug safety watchdog to treat adults with giant cell arteritis, a type of vasculitis.
-
RPS Elections 2017: Candidates face questions in hustings webinar Subscription
Thirteen candidates for this year’s English and Scottish Pharmacy Board elections took part in a hustings webinar hosted by the Royal Pharmaceutical Society on the evening of 16 May 2017.
-
New RPS 'Here For You' initiative celebrates the relationship between pharmacists and their patients Subscription
The Royal Pharmaceutical Society (RPS) has launched an initiative aimed at inspiring pharmacists and imbuing them with “a feeling of pride and satisfaction for the service they provide to patients on a daily basis”.
-
Balloon pill may offer surgery alternative for obese patients
An obesity pill that contains a balloon designed to swell up in the stomach could help patients lose up to two stone in only a few months, research presented at an obesity conference suggests.
-
Cold chains and cool heads: why humanitarian aid needs pharmacists Subscription
The second annual conference of the Humanitarian Aid and Response Network (HARN), held in Brighton on 8 April 2017, brought together humanitarian pharmacists and pharmacy students with a shared interest in international aid work.
-
UK lags behind European neighbours in healthcare index because of performance on cancer
The UK lags behind some of its neighbours in terms of quality of and access to healthcare, results from a study published in The Lancet
-
Welsh Assembly passes Bill to change issuing requirements for new pharmacy dispensing contracts
A bill that includes a provision to replace arrangements for issuing new pharmacy dispensing contracts with a system based on pharmaceutical needs assessments was passed by the Welsh Assembly in Cardiff on 16 May 2017.
-
New compound could improve treatment of lung infection in cystic fibrosis patients
Scientists have developed a new compound that could improve the quality of life of cystic fibrosis patients by increasing the effectiveness of antibiotics in tackling chronic lung infection caused by Pseudomonas aeruginosa.
-
NSAIDS and risk of heart attack Subscription
10 May 2017: Sotiris Antoniou, spokesperson for the Royal Pharmaceutical Society (RPS) on cardiovascular medicine, spoke to the Daily Express about the link between NSAIDs and the risk of heart attack. The article was published ...
-
RPS concern over melatonin to prevent jet lag Subscription
8 May 2017: The Daily Mail published a feature in which 21 doctors were asked which medications they take with them on holiday. One doctor advocated the use of melatonin for prevention of jet lag.
Show 10 per page20 per page50 per page
